Last quarter (Q ), Zenas BioPharma, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Zenas BioPharma, Inc.'s net income was $-37.98M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ 50.00M
Cost of Revenue
-
Gross Profit
$ 50.00M
Operating Expense
$ 87.15M
Operating Income
$ -37.15M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -324.00K
Pretax Income
$ -36.82M
Tax Provision
$ 301.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -37.12M
Basic EPS
-
Diluted EPS
-
Basic Average Shares
$ 13.30M
Diluted Average Shares
$ 13.30M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 87.15M
Net Income From Continuing And Discontinued Operation
$ -37.12M
Normalized Income
$ -27.06M
Interest Expense
-
EBIT
$ -36.82M
EBITDA
$ -36.71M
Currency in USD
Zenas BioPharma, Inc. Earnings and Revenue History